Sinovac Biotech Co., Ltd.

No.39, Shangdi West Road, Haidian District, Beijing, 北京市, China

Clinical Trials

13 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 4

38.2%

Phase 3

30.3%

Phase 1

12.4%

Phase 2

6.7%

Not Applicable

2.3%

Trial Status Distribution

Active, not recruiting

4.5%

Completed

71.9%

Not yet recruiting

10.1%

Recruiting

10.1%

Unknown

2.3%

Withdrawn

1.1%

Clinical Trials

Trials sponsored by this organization (89)

Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children

Not Applicable

Not yet recruiting

interventional

Sep 2026320 participants

Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine

Phase 3

Recruiting

interventional

Aug 2026680 participants

Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Phase 3

Not yet recruiting

interventional

May 20266,000 participants

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months

Phase 3

Recruiting

interventional

Mar 2026880 participants

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months

Phase 3

Recruiting

interventional

Mar 20261,040 participants

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years

Phase 3

Active, not recruiting

interventional

Mar 2026660 participants

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Phase 3

Recruiting

interventional

Mar 20261,040 participants

Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine

Phase 1

Not yet recruiting

interventional

Mar 202660 participants

Page 1 of 12

Approvals

No approval data available

News

No news articles found

Back to Organizations